Ineffectiveness of Probenecid in Theophylline Kinetics and Excretion

Abstract

View all access options for this article.

Brodie

Axelrod

Reichenthal

Metabolism of theophylline (1,3-dimethyl-xanthine) in man. J Biol Chem 1952; 194: 215–22.

Cornish

Christman

. A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem 1957; 228: 315–23.

Jenne

Nagasawa

Thompson

. Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther 1976; 19: 375–81.

Ogilvie

. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 1978; 3: 267–93.

Gutman

. Uricosuric drugs with special references to probenecid and sulfinpyrazone. Adv Pharmacol 1966; 4: 91–142.

Hansten

. Drug interactions, 4th ed. Philadelphia: Lea and Febiger, 1979: 511–52.

Mitenko

Ogilvie

. Pharmacokinetics of intravenous theophylline. Clin Pharmacol Ther 1973; 14: 509–13.

Chen

Twd

Patton

. Effect of probenecid on the pharmacokinetics of aminophylline. Drug Intell Clin Pharm 1983; 17: 465–6.

May

Jarobe

. Inhibition of clearance of dyphylline by probenecid (letter). New Engl J Med 1981; 304: 791.

10.

Simons

FER

. Urinary excretion of dyphylline in humans. J Pharm Sci 1979; 68: 1327–9.

11.

Hendles

Weinberg

Theophylline a “state of the art” review. Pharmacotherapy 1983; 3: 2–44.